An investigation into the precedents of modern drug treatment in psychiatry. Hist Psychiatry
1999; 10: 475–90.
Geddes, J, Freemantle, N, Harrison, P, Bebbington, P.
Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ
2000; 321: 1371–6.
Geddes, JR, Freemantle, N, Mason, J, Eccles, MP, Boynton, J.
SSRIs versus other antidepressants for depressive disorder. Cochrane Database Syst Rev
2000; 2: CD001851.
Donoghue, J, Hylan, TR. Antidepressant use in clinical practice: efficacy v. effectiveness. Br J Psychiatry
2001; 179: s9–17.
Lieberman, JA, Stroup, TS, McEvoy, JP, Swartz, MS, Rosenheck, RA, Perkins, DO, et al Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med
2005; 353: 1209–23.
Moncrieff, J, Wessely, S, Hardy, R.
Antidepressants using active placebos. Cochrane Database Syst Rev
2001; 2: CD003012.
Tyrer, P, Bateman, AW. Drug treatment for personality disorders. Adv Psychiatr Treat
2004; 10: 389–98.
Binks, CA, Fenton, M, McCarthy, L, Lee, T, Adams, CE, Duggan, C.
Pharmacological interventions for people with borderline personality disorder. Cochrane Database Syst Rev
2006; 1: CD005653.
Lieb, K, Völlm, B, Rücker, G, Timmer, A, Stoffers, JM. Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials. Br J Psychiatry
2010; 196: 4–12.
Cornelius, JR, Soloff, PH, Perel, JM, Ulrich, RF. Continuation pharmacotherapy of borderline personality disorder with haloperidol and phenelzine. Am J Psychiatry
1993; 150: 1843–8.
Kendall, T, Pilling, S, Tyrer, P, Duggan, C, Burbeck, R, Meader, N, et al Borderline and antisocial personality disorders: summary of NICE guidance. BMJ
2009; 338: b93.
Hayward, M, Slade, M, Moran, PA. Personality disorders and unmet needs among psychiatric inpatients. Psychiatr Serv
2006; 57: 538–43.
Baker-Glenn, E, Steels, M, Evans, C.
Use of psychotropic medication among psychiatric out-patients with personality disorder. Psychiatrist
2010; 34: 83–6.
Chiesa, M, Wright, M, Leger, D.
Psychotropic medication and the therapeutic community: a survey of prescribing practices for severe personality disorder. Ther Communities
2004; 25: 131–44.
Garrett, C, Lee, T, Blackburn, S, Priestly, L, Bhui, K.
Personality disorder: challenges in service development in the light of the new NICE guidelines. Psychiatrist
2011; 35: 22–6.
Völlm, BA, Chadwick, K, Abdelrazek, T, Smith, J.
Prescribing of psychotropic medication for personality disordered patients in secure forensic settings. J Forens Psychiatry Psychol
2012; 23: 200–16.
National Institute for Health and Clinical Excellence. Borderline Personality Disorder: Treatment and Management (NICE Clinical Guideline 78). NICE, 2009.
National Institute for Health and Care Excellence. Antisocial Personality Disorder: Treatment, Management and Prevention (NICE Clinical Guideline 77). NICE, 2009 (updated 2013).
Scott, IA. Errors in clinical reasoning: causes and remedial strategies. BMJ
2009; 338: b1860.
Doust, J, Del Mar, C.
Why do doctors use treatments that do not work?
2004; 328: 474–5.
Cabana, MD, Rand, CS, Powe, NR, Wu, AW, Wilson, MH, Abboud, P-AC, et al Why don't physicians follow clinical practice guidelines?: a framework for improvement. JAMA
1999; 282: 1458–65.
Solomon, J, Raynor, DK, Knapp, P, Atkin, K.
The compatibility of prescribing guidelines and the doctor-patient partnership: a primary care mixed-methods study. Br J Gen Pract
2012; 62: e275–81.
Hillam, JC, Evans, C.
Neuroleptic drug use in psychiatric intensive therapy units: problems with complying with the consensus statement. Psychiatr Bull
1996; 20: 82–4.
Boyatzis, RE. Transforming Qualitative Information: Thematic Analysis and Code Development. SAGE Publications, 1998.
Braun, V, Clarke, V.
Using thematic analysis in psychology. Qual Res Psychol
2006; 3: 77–101.
Bateman, AW, Fonagy, P.
Handbook of Mentalizing in Mental Health Practice. American Psychiatric Publishing, 2012.
The ailment. Br J Med Psychol
1957; 30: 129–45.
Bateman, A, Fonagy, P (eds). Using the mentalization model to understand severe personality disorder. In Mentalization-Based Treatment for Borderline Personality Disorder: A Practical Guide. Oxford University Press, 2006.
Butler, CC, Rollnick, S, Pill, R, Maggs-Rapport, F, Stott, N.
Understanding the culture of prescribing: qualitative study of general practitioners' and patients' perceptions of antibiotics for sore throats. BMJ
1998; 317: 637–42.
Croskerry, P, Abbass, AA, Wu, AW. How doctors feel: affective issues in patients' safety. Lancet
2008; 372: 1205–6.
Psychiatric diagnosis under conditions of uncertainty: personality disorder, science and professional legitimacy. Sociol Health Ill
2000; 22: 621–40.
Milton, J, McCartney, M, Duggan, C, Evans, C, Collins, M, McCarthy, L, et al Beauty in the eye of the beholder? How high security hospital psychopathically-disordered patients rate their own interpersonal behaviour. J Forens Psychiatry Psychol
2005; 16: 552–65.
Huband, N, Evans, C, Duggan, C, Khan, O.
Personality disorder traits and self-reported target problems in a treatment-seeking sample. Clin Psychol Psychother
2012; Dec 6, doi: 10.1002/cpp.1825.
Huband, N, McMurran, M, Evans, C, Duggan, C.
Social problem-solving plus psychoeducation for adults with personality disorder. Pragmatic randomised controlled trial. Br J Psychiatry
2007; 190: 307–13.
Moncrieff, J, Cohen, D.
How do psychiatric drugs work?
2009; 338: b1963.
Medication prescribed to people with personality disorder: the influence of patient factors and treatment setting. Acta Psychiatr Scand
2011; 124: 396–402.
Hillam, J, Evans, C, Borrell, T, Davies, N.
The management of severe psychiatric disorder: a comparison of the use of neuroleptic medication in two intensive therapy units. J Forens Psychiatry
1997; 8: 679–88.
Unnecessary care: are doctors in denial and is profit driven healthcare to blame?
2012; 345: e6230.
Overtreatment, over here. BMJ
2012; 345: e6684.
Bracken, P, Thomas, P, Timimi, S, Asen, E, Behr, G, Beuster, C, et al Psychiatry beyond the current paradigm. Br J Psychiatry
2012; 201: 430–4.
The process of managing medications in patients with borderline personality disorder. J Psychiatr Pract
2011; 17: 311–20.
Death, taxes, certainties, groups and communities or NICE and the Deathly Hallows. Ther Communities
2010; 31: 321.
McPherson, S, Evans, C, Richardson, P.
The NICE depression guidelines and the recovery model: is there an evidence base for IAPT?
J Ment Health
2009; 18: 405–14.